Gregory J Flesher - Chief Executive Officer, Novus Therapeutics, Inc

As of March 20, 2020


Gregory J Flesher Net Worth

  • Net worth is estimated to be at least $70.17K
  • Owns at least 156,918 units of Novus Therapeutics, Inc stock
  • Sold an estimated value of $28.57K in the last 3 years at Novus Therapeutics, Inc

Gregory J Flesher Trading

  • Largest purchase of shares was 58,959 units , worth over $589K on May 11, 2017
  • Largest sale of shares was 14,638 units , worth over $28.57K on May 22, 2019
  • In total has made about 7 transactions over 3 years
  • Usually trades in May and March, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Gregory J Flesher Mailing Address

  • Mailing address is 19900 MacArthur Blvd., Suite 550 Irvine CA 92612 CA

Novus Therapeutics, Inc Insider Trading

  • The most recent transaction was 103,200 units sold on December 4, 2020 by Orbimed Israel GP Ltd and Partnership Limited GP Biofund Israel Orbimed worth over $2.23M
  • In the last 3 years, insiders at Novus Therapeutics, Inc sold an estimated value of $2.63M and bought an estimated value of $7.31M
  • The most active traders are Catherine C Turkel, President,  Gregory J Flesher, Chief Executive Officer,  and Jon Kuwahara, See Remarks
  • Insider trading is most common in May, with the busiest year in 2019

Eledon Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1